Real-World Experience in Diagnosing and Managing PNH in Special Patient Populations
Expert Commentary and Case Reviews
Click the"View Activity" button to view this activity.View Activity
CME/CE is no longer available for this activity
• Discuss real-world experience in diagnosing and treating PNH in special patient populations
• Formulate personalized treatment strategies considerate of patient risks, characteristics, complications, and preferences
• Discuss coordination of care and clinical strategies amongst specialists to improve patient outcomes
Sponsored by Rush University Medical Center and the Academy for Continued Healthcare Learning (ACHL).
Professor of Medicine and Pathology
Rush University Medical Center
As a provider of continuing education, Rush University Medical Center requires everyone who has the ability to control or influence the content of an educational activity to disclose information about all of their financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, with ineligible companies. Individuals must disclose regardless of their view of the relevance of the relationship to the education. Mechanisms are in place to identify and mitigate any potential conflicts of interest prior to the start of the activity.
Speakers' Bureau: Alexion Pharmaceuticals, Inc
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Potential use of eculizumab, ravulizumab, and pegcetacoplan during pregnancy; investigational therapies for the treatment of PNH: ABP 959, SB12, BCD-148, crovalimab, SKY59, RO7112689, tesidolumab, LFG316, pozelimab, REGN3918, zilucoplan, RA101495, nomacopan, VA576, coversin, cemdisiran, ALN-CC5, danicopan, ACH-4471, BCX9930, iptacopan, LNP023
In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity is being presented without bias and with commercial support.